140 related articles for article (PubMed ID: 24394303)
1. CD30-negative lymphomatoid papulosis type D in an elderly man.
Cho-Vega JH; Vega F
Am J Dermatopathol; 2014 Feb; 36(2):190-2. PubMed ID: 24394303
[No Abstract] [Full Text] [Related]
2. Lymphomatoid papulosis and recurrent transitional cell carcinoma of the bladder: a paraneoplastic association.
Leon WM; Aw CW; Tran KB
Dermatol Online J; 2014 Apr; 20(4):22369. PubMed ID: 24746306
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic challenge. Regional lymphomatoid papulosis, type A.
Sharma V; Xu G; Petronic-Rosic V; Gerami P
Int J Dermatol; 2007 Sep; 46(9):905-9. PubMed ID: 17822490
[No Abstract] [Full Text] [Related]
4. [Cutaneous neutrophils infiltrates. Case 7. Lymphomatoid papulosis].
Vergier B
Ann Pathol; 2011 Jun; 31(3):198-202. PubMed ID: 21737002
[No Abstract] [Full Text] [Related]
5. Lymphomatoid papulosis and cutaneous CD30+ lymphoma.
LeBoit PE
Am J Dermatopathol; 1996 Jun; 18(3):221-35. PubMed ID: 8806956
[TBL] [Abstract][Full Text] [Related]
6. Case of regional lymphomatoid papulosis confined to the periorbital areas.
Kim YJ; Rho YK; Yoo KH; Kim JY; Seo SJ; Hong CK; Moon NJ; Song KY
J Dermatol; 2009 Mar; 36(3):163-5. PubMed ID: 19335692
[TBL] [Abstract][Full Text] [Related]
7. Lymphomatoid papulosis type E with a CD56+ immunophenotype presenting with purpura-like lesions.
Ba W; Yin G; Yang J; Zhang Z; Wang W; Zhao Z; Chen H; Li C
J Cutan Pathol; 2019 Jul; 46(7):542-545. PubMed ID: 30957244
[TBL] [Abstract][Full Text] [Related]
8. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
Scarisbrick JJ; Calonje E; Orchard G; Child FJ; Russell-Jones R
J Am Acad Dermatol; 2001 Feb; 44(2):239-47. PubMed ID: 11174381
[TBL] [Abstract][Full Text] [Related]
9. Persistent agmination of lymphomatoid papulosis.
Torrelo A; Colmenero I; Hernández A; Goiriz R
Pediatr Dermatol; 2009; 26(6):762-4. PubMed ID: 20199467
[TBL] [Abstract][Full Text] [Related]
10. Case records of the Massachusetts General Hospital. Case 5-2015. A 69-year-old woman with recurrent skin lesions after treatment for lymphoma.
LeBoeuf NR; McDermott S; Harris NL
N Engl J Med; 2015 Feb; 372(7):650-9. PubMed ID: 25671258
[No Abstract] [Full Text] [Related]
11. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
[TBL] [Abstract][Full Text] [Related]
12. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
McQuitty E; Curry JL; Tetzlaff MT; Prieto VG; Duvic M; Torres-Cabala C
J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
[TBL] [Abstract][Full Text] [Related]
13. Epidermotropic CD8 positive lymphoproliferative diseases: histological and immunophenotypic similarities but markedly differing clinical behaviour.
Paton DJ; Van Vliet C; Prasad Kumarasinghe S; Chan JJ; Wood BA
Pathology; 2016 Dec; 48(7):733-736. PubMed ID: 27814904
[No Abstract] [Full Text] [Related]
14. Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
Andersen RM; Larsen MS; Poulsen TS; Lauritzen AF; Skov L
Acta Derm Venereol; 2014 Jul; 94(4):474-5. PubMed ID: 24217891
[No Abstract] [Full Text] [Related]
15. Unilesional locally recurrent lymphomatoid papulosis with variable histological presentation.
Wehkamp U; Weichenthal M; Klapper W; Schwarz T; Oschlies I
Leuk Lymphoma; 2018 Jan; 59(1):262-264. PubMed ID: 28562138
[No Abstract] [Full Text] [Related]
16. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
17. Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma.
Cardoso J; Duhra P; Thway Y; Calonje E
Am J Dermatopathol; 2012 Oct; 34(7):762-5. PubMed ID: 22688398
[TBL] [Abstract][Full Text] [Related]
18. Persistent agmination of lymphomatoid papulosis: an ongoing debate.
Pileri A; Bacci F; Neri I; Ciabatti S; Stefoni V; Zinzani PL; Patrizi A
Dermatology; 2012; 225(2):131-4. PubMed ID: 22986223
[TBL] [Abstract][Full Text] [Related]
19. The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative).
Gellrich S; Wernicke M; Wilks A; Lukowsky A; Muche JM; Jasch KC; Audring H; Mason D; Sterry W
J Invest Dermatol; 2004 Mar; 122(3):859-61. PubMed ID: 15086582
[No Abstract] [Full Text] [Related]
20. IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils.
Slone SP; Martin AW; Wellhausen SR; Woods DR; Malone JC; Lear SC; Laber DA
J Cutan Pathol; 2008 Oct; 35 Suppl 1():38-45. PubMed ID: 18537857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
